US SB340 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on February 5 2019 - 25% progression, died in chamber
Action: 2019-02-06 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

CREATES Act of 2019 Creating and Restoring Equal Access to Equivalent Samples Act of 2019

Sponsors


History

DateChamberAction
2019-02-06SenateRead the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
2019-02-05SenateIntroduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. (Sponsor introductory remarks on measure: CR S868-869)

Same As/Similar To

HB965 (Same As) 2019-05-16 - Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
HB2700 (Related) 2019-06-26 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Subjects


US Congress State Sources


Bill Comments

feedback